The last thing a person wants to hear from their doctor is “You have cancer.” Unfortunately, that’s the reality for the thousands of Americans, including many Latinos, diagnosed with cancer each year. After a diagnosis, people dealing with cancer discuss treatment options with their medical care team, which may include participation in clinical trials. Clinical trials are studies with volunteers that test ways to find, prevent, and treat cancer and other diseases. They may also help improve the quality of life for volunteers affected by cancer or reduce the side effects of treatment. Despite the benefits of participating in clinical trials, only about one out of every five (21.9%) people with cancer enroll in clinical research, according to a new study in the ...
Clinical trials have led to the development of better treatments, life-saving medicines, and new prevention strategies for cancer and other diseases. Still, clinical trials have lacked volunteers who are Latino. We need diverse representation in clinical trials to ensure health and medical discoveries are equitable for diverse populations. To promote clinical trials, let’s use #SaludTues on Tuesday, Dec. 5, 2023, to discuss reasons why Latinos and all people should consider joining a clinical trial! WHAT: #SaludTues Tweetchat: Why Should You Try a Clinical Trial?
TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, Dec. 5, 2023
WHERE: On Twitter with hashtag #SaludTues
HOST: @SaludAmerica
CO-HOSTS: Latinx Voces LLC (@latinxvocesllc); LatinaStrong Foundation ...
Most people with COVID-19 get better within a few days to a few weeks after COVID-19 infection. But some people, including many Latinos, develop long COVID. Long COVID remains an unresolved threat to the health of Latinos and all people. While health experts don’t yet fully understand long COVID symptoms and risk factors, progress is being made regarding treatment. Let’s learn more about how researchers are working to find the most effective therapies for long COVID through research studies and clinical trials.
Relieving the Burden of Long COVID Symptoms
The National Institutes of Health (NIH) launched the RECOVER research study in 2021 to learn why some people experience long COVID or develop new or returning symptoms after COVID-19 infection. Now, based on ...
Despite the ever-growing population of Latinos in the United States, only a very small percentage participate in clinical trials. Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. “This massive underrepresentation of Latinos in clinical trials makes it hard for researchers to develop new treatments for this group, which suffers a heavy burden of cancer, Alzheimer’s, and other diseases,” said Dr. Amelie Ramirez, director of the Salud America! program at UT Health San Antonio. Do you know what happens in a clinical trial? How can clinical trial help you and your friends, family, and community? Why is Latino participation in clinical trials important? Get answers and helpful resources in new bilingual ...
Some Latinos fear becoming a guinea pig. Others worry about cost or trust. But clinical trials can provide volunteers potentially life-saving treatments and help researchers learn how to manage and treat different diseases for their family and communities. UT Health San Antonio held a Zoom webinar — “Busting the Myths and Cultural Barriers to Clinical Trials” — at 11 a.m. CT on March 9, 2023. This webinar features health experts and real Latino clinical trial volunteers to help define clinical trials, bust several common cultural, social, and logistical myths about clinical trials, and share testimonials of trial participation. Panelists will also connect audience members with culturally relevant resources and available opportunities to participate in clinical trials ...
Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. There are four phases of clinical trials that each help scientists answer different questions. Phase 1 clinical trials are the first step in testing a new treatment in people. They focus on evaluating the safety, side effects, best dose, and timing of a new treatment, according to the National Cancer Institute (NCI). Phase 1 clinical trials usually include a small number of patients who have not been helped by other treatments. In the past, participants in phase 1 trials for cancer treatment generally had low tumor response rates. And, because phase 1 trials are focused on assessing safety of treatments, doctors have hesitated to refer patients to these ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Novel Therapeutic Approach to Reduce Health Disparity in B-cell Acute Lymphoblastic Leukemia in Hispanic/Latino Children
Dr. Sinisa Dovat is Professor of Pediatrics, Pharmacology, and Biochemistry and Molecular Biology at Pennsylvania State University College of Medicine. He is also Four Diamond Endowed Chair and Director of Translational Research and Experimental Therapeutics in Pediatric Hematology/Oncology at Penn State University. B-Cell acute lymphoblastic leukemia and Hispanic children B-Cell acute lymphoblastic leukemia (B-ALL) ...
We all want the best for our children. While the thought of enrolling your child in a clinical trial may sound scary, but there are plenty of benefits to trial participation. Some of these benefits include diagnosing, preventing, treating, and sometimes even curing childhood diseases. However, there are some potential risks to trial participation, too. Here’s everything you need to know about enrolling your child in a clinical trial.
What is a Clinical Trial?
Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. There are different kinds of clinical trials with different intended purposes. There are also four phases of clinical trials that each help scientists answer different ...
Clinical trials are the most safe, rigorous way of testing for new and more effective disease treatments. Although Latinos comprise 18.9% of the US population, they make up just 10% of participants in clinical trials run by the National Cancer Institute and 4% of drug trials run by the FDA. This massive underrepresentation of Latinos in clinical trials makes it hard for researchers to develop new treatments for this group, which suffers a heavy burden of cancer, Alzheimer’s, and other diseases. Further, diseases present differently in Latinos than White populations – who traditionally make up most clinical trial participants. For example, Latinos on average present symptoms of Alzheimer’s approximately seven years earlier than other racial and ethnic groups, and are ...
